Related Experiment Video
Updated: Oct 16, 2025
Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Engineering of Human Lactoferrin for Improved Anticancer Activity
Yu Pan1, Niying Chua2, Kaisheng Lim1
1Department of Biomedical Engineering, Southern University of Science and Technology (SUSTech), Shenzhen, China.
Engineered lactoferrin fragments show potent anticancer activity. This novel recombinant human lactoferrin fragment (rtHLF4) is a promising, safer alternative to chemotherapy, with no observed hemolytic activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Protease-digested lactoferrin fragments may possess enhanced therapeutic benefits.
- Limited research exists on the anticancer properties of lactoferrin fragments.
- Lactoferrin fragments offer a potential alternative to chemotherapy due to fewer side effects.
Purpose of the Study:
- To isolate and characterize a recombinant engineered-lactoferrin fragment (rtHLF4).
- To evaluate the anticancer activity and safety profile of rtHLF4.
- To investigate the molecular mechanisms underlying rtHLF4's anticancer effects.
Main Methods:
- Isolation and characterization of recombinant engineered-lactoferrin (rtHLF4).
- Anticancer activity assays comparing rtHLF4 to full-length lactoferrin (flHLF).
- Transcriptomic analysis of cancer biomarkers, including apoptosis, angiogenesis, and metastasis.
- Hemolytic activity assays.
Main Results:
- rtHLF4 demonstrated up to 100-fold greater anticancer activity than flHLF.
- rtHLF4 exhibited anticancer effects in a shorter treatment duration.
- Transcriptomic analysis revealed rtHLF4 upregulates pro-apoptotic markers and downregulates angiogenesis/metastasis proteins.
- No hemolytic activity was observed for rtHLF4 at high concentrations.
Conclusions:
- rtHLF4 is a potent anticancer agent with enhanced efficacy and safety.
- rtHLF4 represents a promising candidate for further development as a novel cancer therapeutic.
- The molecular mechanisms involve modulation of key cancer-related pathways.
More Related Videos
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014